Article
Clinical efficacy analysis of Osimertinib treatment for a patient with leptomeningeal metastasis of EGFR+ non-small cell lung cancer without the T790M mutation.
Annals of palliative medicine - 1 Nov 2019
Hu Xueyang, Chen Wenjun, Li Xiaoqiu, Zhao Chenchen, Zhang Congjun, Xiong Fuxing, Wu Hongyang
Abstract excerpt
BACKGROUND: To find the method of therapy of leptomeningeal metastasis (LM) to non-small cell lung cancer (NSCLC) patient with EGFR mutation (EGFR+) but without T790M mutation. METHODS: A retrospective analysis was reviewed for 5 NSCLC patients with EGFR+ who develop to LM from January 2018 to February 2019 in our hospital. RESULTS: All five NSCLC cases were adenocarcinoma, four cases were verified existed EGFR...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.